Xencor IPO Research Information

Xencor IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Xencor, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Xencor	XNCR - NASDAQ	Priced at $5.50	$0.00	$0.00	12.7 million	12/3/2013
Underwriter(s): Credit Suisse, Leerink Swann, Wedbush PacGrow Life Sciences
Co-Manager(s):
Industry:
Filing(s): Filed 2013-10-11

About Xencor (adapted from Xencor prospectus):
They are a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "XNCR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.